Greetings, and welcome to the Edwards Lifesciences Corporation Fourth Quarter 2013 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded.
The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.
Research and Markets: Global Central Venous Access Devices Market 2014-2018: Becton, Dickinson and Co., Cook Medical Inc., C.R Bard Inc. and Teleflex Inc Among Top Vendors
Ownership data provide a look at who else owns the company.
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...